Medicine
Feiba kit
Feiba kit is a prescription medicine containing Anti-inhibitor coagulant complex, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. Store at 36°F to 77°F (2°C to 25°C) Store in the original…
Key facts
- Active ingredient (INN)
- Anti-inhibitor coagulant complex
- Brand
- Feiba
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Takeda Pharmaceuticals
- Manufacturer
- Takeda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 36°F to 77°F (2°C to 25°C) Store in the original package in order to protect from light. Prior to preparation and reconstitution, allow the vials of FEIBA and Sterile Water for Injection (diluent) to reach room temperature, if refrigerated.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 January 1986
- Identifiers
- RxCUI 1659998, 1660001DailyMed set ID 752604e5-4ea2-44f4-83ed-1569373f6412NDC 64193-425, 64193-424, 64193-426Application BLA101447
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 20 mL in 1 vial, glass * 20 mL in 1 vial, glass | 64193-424-02 | Takeda Pharmaceuticals | 31 January 1986 |
| 1 kit in 1 carton * 50 mL in 1 vial, glass * 50 mL in 1 vial, glass | 64193-425-02 | Takeda Pharmaceuticals | 31 January 1986 |
| 1 kit in 1 carton * 10 mL in 1 vial, glass * 10 mL in 1 vial, glass | 64193-426-02 | Takeda Pharmaceuticals | 31 January 1986 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Anti-inhibitor coagulant complex is a prescription medicine. It is available as kits. MedsAcross supplies Anti-inhibitor coagulant complex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Anti-inhibitor coagulant complexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FEIBA prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Feiba kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.